SubscribeAll Posts Tagged With: "health care"
AmerisourceBergen Corporation: Increase the Health of your Portfolio
Several weeks ago, we focused on the distribution side of the health care industry as yet another overlooked area that should continue to do well during our economic downturn.
We discussed one of the largest “Grainger-like” companies in the health care industry, Cardinal Health, Inc. (NYSE: CAH). Cardinal is an $87 billion global manufacturer, supplier and distributor of medical products.
Given the sheer size of the medical equipment and drug market – the global pharmaceutical market alone is estimated to be north of $700 billion annually – it shouldn’t be too surprising that Cardinal has…
4Mar2009 | Investment U | Comments Off | ContinuedMoney Morning Outlook 2009: Obamanomics Offers Investors Plenty of Profit Plays in the New Year
With his landslide election victory Tuesday – coupled with Democratic gains in the House of Representatives and in the Senate – U.S. President-elect Barack H. Obama II will have the ability to pursue more or less any policy he wants.
For investors who have been trying to analyze the economic outlook for the New Year, the election of U.S. Sen. Obama (D-Ill.) provides a major piece of the forward-looking jigsaw puzzle that these analysts hope to assemble. That’s because the likely trends of the United States and other economies around the world – and the relative…
6Nov2008 | Money Morning | Comments Off | ContinuedSmall-Cap Vaccines
Small Wonders
The media have dubbed it “the new age of epidemics.†From SARS to cancer, diabetes to the flu, we live in a world of increasingly powerful germs and diseases.
Drug companies large and small have renewed their interest in one specific health care sector. It’s a true form of preventative medicine — a rapidly growing field that’s already decimated countless dangerous and deadly diseases.
Now biotechs and Big Pharma are in a race against time. Their mission is clear: Rid the world of the onslaught of superbugs and diseases that could cause the next great epidemic. And they’ll…
24Jul2008 | Whiskey and Gunpowder | Comments Off | ContinuedWith a $3.1 Billion Program, Europe Hopes to Regain Position as Top Drug-Development Market in the World
In a bid to re-establish itself as the “pharmacy of the world†– and narrow the growing gap between itself and the United States and Asia – Europe is launching a $3.1 billion drug-discovery initiative.
The program – known as the “Innovative Medicines Initiative†– was unveiled in Belgium, and offers financial grants to both academic institutions and small companies to research ways of beating bottlenecks in the drug-development process. The work is “pre-competitive,†meaning it involves issues that are common to drug development, and doesn’t give any individual company a competitive advantage.
At one time, Europe was the worldwide…
16Jun2008 | Money Morning | Comments Off | Continued
Loading ...
